Advisory Research’s St Jude Medical STJ Stock Holding History

Advisory Research’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,028	Closed	-$67K	–	759
2014 Q1	$67K	Buy	+1,028	New	+$66.9K	﹤0.01%	680

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IIS

Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Advisory Research's STJ Position: Q2 2014 in Review

Advisory Research sold out of St Jude Medical (STJ) in Q2 2014, closing a stake of 1,028 shares — an estimated $67K sold.

Advisory Research first reported a position in STJ in Q1 2014 and held it in 1 quarter. The position peaked at $67K in Q1 2014. 555 funds tracked by Wall St. Rank hold STJ as of Q2 2014.

Advisory Research reported no remaining St Jude Medical position as of Q2 2014 after selling out during the quarter.
Advisory Research sold 1,028 St Jude Medical shares in Q2 2014, an estimated $67K.
Advisory Research first reported a position in St Jude Medical in Q1 2014 and held it in 1 quarter.
Advisory Research's St Jude Medical position peaked at $67K in Q1 2014.
555 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2014.

Based on Advisory Research's 13F filing for Q2 2014, filed 14 Aug 2014.